Dosing and side-effects of ifosfamide plus mesna
- 1 July 1991
- journal article
- review article
- Published by Springer Nature in Zeitschrift für Krebsforschung und Klinische Onkologie
- Vol. 117 (S4) , S164-S186
- https://doi.org/10.1007/bf01613224
Abstract
No abstract availableKeywords
This publication has 134 references indexed in Scilit:
- Ifosfamide-induced renal tubular dysfunction and rickets in children with Wilms tumorThe Journal of Pediatrics, 1990
- Inappropriate antidiuretic hormone secretion induced by ifosfamideEuropean Journal of Cancer and Clinical Oncology, 1990
- Pilot study of neoadjuvant ifosfamide, cisplatin, and etoposide in locally advanced non-small cell lung cancerEuropean Journal of Cancer and Clinical Oncology, 1990
- Ifosfamide encephalopathy: a reappraisalEuropean Journal of Cancer and Clinical Oncology, 1989
- An EORTC gastrointestinal group phase II evaluation of epirubicin combined with ifosfamide in advanced adenocarcinoma of the pancreasEuropean Journal of Cancer and Clinical Oncology, 1989
- IFOSFAMIDE-INDUCED FANCONI SYNDROMEThe Lancet, 1989
- A phase I–II study of ifosfamide in combination with adriamycin in the treatment of adult soft tissue sarcomaEuropean Journal of Cancer and Clinical Oncology, 1988
- Cyclophosphamide versus ifosfamide: Final report of a randomized phase II trial in adult soft tissue sarcomasEuropean Journal of Cancer and Clinical Oncology, 1987
- Failure of 2-mercaptoethane sulphonate sodium (mesna) to protect against ifosfamide nephrotoxicityEuropean Journal of Cancer and Clinical Oncology, 1984
- Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention—IPublished by Elsevier ,1981